The potential role of milk-derived peptides in cardiovascular disease (Q37903711)

25 August 2017

1 reference

title

The potential role of milk-derived peptides in cardiovascular disease (English)

1 reference

25 August 2017

cardiovascular disease

1 reference

Martha Phelan

1

1 reference

PubMed ID

21779574

25 August 2017

David Kerins

series ordinal

2

1 reference

25 August 2017

29 March 2011

1 reference

25 August 2017

1 reference

25 August 2017

2

1 reference

25 August 2017

153-167

1 reference

25 August 2017

3-4

1 reference

Latent bioactive peptides in milk proteins: proteolytic activation and significance in dairy processing

25 August 2017

1 reference

https://api.crossref.org/works/10.1039%2FC1FO10017C

Bioactive milk peptides: a prospectus

21 January 2018

1 reference

https://api.crossref.org/works/10.1039%2FC1FO10017C

Structures and functionalities of milk proteins

21 January 2018

1 reference

https://api.crossref.org/works/10.1039%2FC1FO10017C

Angiotensin converting enzyme inhibitory activity in commercial fermented products. Formation of peptides under simulated gastrointestinal digestion.

21 January 2018

1 reference

https://api.crossref.org/works/10.1039%2FC1FO10017C

Putting microbes to work: dairy fermentation, cell factories and bioactive peptides. Part II: bioactive peptide functions

21 January 2018

1 reference

https://api.crossref.org/works/10.1039%2FC1FO10017C

Antihypertensive effect of the peptides derived from casein by an extracellular proteinase from Lactobacillus helveticus CP790.

21 January 2018

1 reference

https://api.crossref.org/works/10.1039%2FC1FO10017C

Inhibition by lactoferrin and kappa-casein glycomacropeptide of binding of Cholera toxin to its receptor

21 January 2018

1 reference

https://api.crossref.org/works/10.1039%2FC1FO10017C

Opioid receptor ligands derived from food proteins

21 January 2018

1 reference

https://api.crossref.org/works/10.1039%2FC1FO10017C

Antibacterial and immunostimulating casein-derived substances from milk: casecidin, isracidin peptides

21 January 2018

1 reference

https://api.crossref.org/works/10.1039%2FC1FO10017C

Database of biologically active peptide sequences

21 January 2018

1 reference

https://api.crossref.org/works/10.1039%2FC1FO10017C

Kappacin, a novel antibacterial peptide from bovine milk.

21 January 2018

1 reference

https://api.crossref.org/works/10.1039%2FC1FO10017C

Biofunctional peptides from milk proteins: mineral binding and cytomodulatory effects

21 January 2018

1 reference

https://api.crossref.org/works/10.1039%2FC1FO10017C

Biologically active peptides in milk proteins

21 January 2018

1 reference

https://api.crossref.org/works/10.1039%2FC1FO10017C

Biologically active peptides from milk proteins with emphasis on two examples concerning antithrombotic and immunomodulating activities

21 January 2018

1 reference

https://api.crossref.org/works/10.1039%2FC1FO10017C

Global mortality, disability, and the contribution of risk factors: Global Burden of Disease Study

21 January 2018

1 reference

https://api.crossref.org/works/10.1039%2FC1FO10017C

Role of angiotensinogen in the genetics of essential hypertension

21 January 2018

1 reference

https://api.crossref.org/works/10.1039%2FC1FO10017C

Platelet activity and salt sensitivity in the pathogenesis of systemic (essential) hypertension in black Africans

21 January 2018

1 reference

https://api.crossref.org/works/10.1039%2FC1FO10017C

Hemostatic factors and the risk of myocardial infarction or sudden death in patients with angina pectoris. European Concerted Action on Thrombosis and Disabilities Angina Pectoris Study Group

21 January 2018

1 reference

https://api.crossref.org/works/10.1039%2FC1FO10017C

Resolved and unresolved issues in the prevention and treatment of coronary artery disease: a workshop consensus statement

21 January 2018

1 reference

https://api.crossref.org/works/10.1039%2FC1FO10017C

Global burden of hypertension: analysis of worldwide data

21 January 2018

1 reference

https://api.crossref.org/works/10.1039%2FC1FO10017C

Effect of race and hypertension on plasma amylin concentrations

21 January 2018

1 reference

https://api.crossref.org/works/10.1039%2FC1FO10017C

Blood pressure, stroke, and coronary heart disease. Part 1, Prolonged differences in blood pressure: prospective observational studies corrected for the regression dilution bias

21 January 2018

1 reference

https://api.crossref.org/works/10.1039%2FC1FO10017C

Is high blood pressure a late manifestation of the hypertension syndrome?

21 January 2018

1 reference

https://api.crossref.org/works/10.1039%2FC1FO10017C

The future of hypertension therapy: sense, antisense, or nonsense?

21 January 2018

1 reference

https://api.crossref.org/works/10.1039%2FC1FO10017C

Angiotensin-converting enzyme: new concepts concerning its biological role

21 January 2018

1 reference

https://api.crossref.org/works/10.1039%2FC1FO10017C

21 January 2018

Vasopeptidase inhibitors

1 reference

https://api.crossref.org/works/10.1039%2FC1FO10017C

The angiotensin converting enzyme (ACE).

21 January 2018

1 reference

https://api.crossref.org/works/10.1039%2FC1FO10017C

Current concepts of the pathogenesis of the acute coronary syndromes

21 January 2018

1 reference

https://api.crossref.org/works/10.1039%2FC1FO10017C

The role of the platelet in the pathogenesis of atherothrombosis

21 January 2018

1 reference

https://api.crossref.org/works/10.1039%2FC1FO10017C

Platelet-collagen interaction: is GPVI the central receptor?

21 January 2018

1 reference

https://api.crossref.org/works/10.1039%2FC1FO10017C

Signaling events underlying thrombus formation

21 January 2018

1 reference

https://api.crossref.org/works/10.1039%2FC1FO10017C

Platelet interactions in thrombosis

21 January 2018

1 reference

https://api.crossref.org/works/10.1039%2FC1FO10017C

The role of collagen in thrombosis and hemostasis

21 January 2018

1 reference

https://api.crossref.org/works/10.1039%2FC1FO10017C

Role of platelets in coronary thrombosis and reperfusion of ischemic myocardium

21 January 2018

1 reference

https://api.crossref.org/works/10.1039%2FC1FO10017C

New insights into the structural basis of integrin activation.

21 January 2018

1 reference

https://api.crossref.org/works/10.1039%2FC1FO10017C

Advantages of fast-acting ADP receptor blockade in ischemic heart disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1039%2FC1FO10017C

Central role of the P2Y12 receptor in platelet activation

21 January 2018

1 reference

https://api.crossref.org/works/10.1039%2FC1FO10017C

The evolving role of platelets in inflammation.

21 January 2018

1 reference

https://api.crossref.org/works/10.1039%2FC1FO10017C

Scientific and therapeutic advances in antiplatelet therapy

21 January 2018

1 reference

https://api.crossref.org/works/10.1039%2FC1FO10017C

A critical role of platelet adhesion in the initiation of atherosclerotic lesion formation

21 January 2018

1 reference

https://api.crossref.org/works/10.1039%2FC1FO10017C

Platelet indexes in relation to target organ damage in high-risk hypertensive patients: a substudy of the Anglo-Scandinavian Cardiac Outcomes Trial (ASCOT)

21 January 2018

1 reference

https://api.crossref.org/works/10.1039%2FC1FO10017C

Differential induction of P-selectin expression on platelets by two cell separators during plateletpheresis and the effect of gender on the release of soluble P-selectin.

21 January 2018

1 reference

https://api.crossref.org/works/10.1039%2FC1FO10017C

Localization of atherosclerosis: role of hemodynamics

21 January 2018

1 reference

https://api.crossref.org/works/10.1039%2FC1FO10017C

Targeting platelets for prevention and treatment of cardiovascular disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1039%2FC1FO10017C

Effects of cyclic nucleotides and protein kinases on platelet calcium homeostasis and mobilization.

21 January 2018

1 reference

https://api.crossref.org/works/10.1039%2FC1FO10017C

Effects of angiotensin II and endothelin-1 on platelet aggregation and cytosolic pH and free Ca2+ concentrations in essential hypertension

21 January 2018

1 reference

https://api.crossref.org/works/10.1039%2FC1FO10017C

Reactive oxygen species: players in the platelet game

21 January 2018

1 reference

https://api.crossref.org/works/10.1039%2FC1FO10017C

Platelet NAD(P)H-oxidase-generated ROS production regulates alphaIIbbeta3-integrin activation independent of the NO/cGMP pathway

21 January 2018

1 reference

https://api.crossref.org/works/10.1039%2FC1FO10017C

Nitric oxide: a physiologic messenger molecule

21 January 2018

1 reference

https://api.crossref.org/works/10.1039%2FC1FO10017C

Endothelium-dependent inhibition of platelet aggregation

21 January 2018

1 reference

https://api.crossref.org/works/10.1039%2FC1FO10017C

S-nitrosocysteine inhibition of human platelet secretion is correlated with increases in platelet cGMP levels

21 January 2018

1 reference

https://api.crossref.org/works/10.1039%2FC1FO10017C

Endothelium-derived relaxing factor reduces platelet adhesion to bovine endothelial cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1039%2FC1FO10017C

Effects of antihypertensive drugs on plasma lipids

21 January 2018

1 reference

https://api.crossref.org/works/10.1039%2FC1FO10017C

Drug-induced angioedema without urticaria

21 January 2018

1 reference

https://api.crossref.org/works/10.1039%2FC1FO10017C

Nutritional factors in the pathobiology of human essential hypertension

21 January 2018

1 reference

https://api.crossref.org/works/10.1039%2FC1FO10017C

Isolation and structural analysis of antihypertensive peptides that exist naturally in Gouda cheese.

21 January 2018

1 reference

https://api.crossref.org/works/10.1039%2FC1FO10017C

Release of short and proline-rich antihypertensive peptides from casein hydrolysate with an Aspergillus oryzae protease

21 January 2018

1 reference

https://api.crossref.org/works/10.1039%2FC1FO10017C

A quantitative in silico analysis calculates the angiotensin I converting enzyme (ACE) inhibitory activity in pea and whey protein digests.

21 January 2018

1 reference

https://api.crossref.org/works/10.1039%2FC1FO10017C

Biochemical properties of peptides encrypted in bovine milk proteins

21 January 2018

1 reference

https://api.crossref.org/works/10.1039%2FC1FO10017C

Food-derived peptides with biological activity: from research to food applications

21 January 2018

1 reference

https://api.crossref.org/works/10.1039%2FC1FO10017C

Angiotensin-converting enzyme inhibitors: Medicinal chemistry and biological actions

21 January 2018

1 reference

https://api.crossref.org/works/10.1039%2FC1FO10017C

Update on newer antihypertensive medicines and interventions

21 January 2018

1 reference

https://api.crossref.org/works/10.1039%2FC1FO10017C

Angiotensin-I-converting enzyme and its relatives

21 January 2018

1 reference

https://api.crossref.org/works/10.1039%2FC1FO10017C

Peptidase specificity characterization of C- and N-terminal catalytic sites of angiotensin I-converting enzyme.

21 January 2018

1 reference

https://api.crossref.org/works/10.1039%2FC1FO10017C

The hemoregulatory peptide N-acetyl-Ser-Asp-Lys-Pro is a natural and specific substrate of the N-terminal active site of human angiotensin-converting enzyme

21 January 2018

1 reference

https://api.crossref.org/works/10.1039%2FC1FO10017C

Blood pressure, stroke, and coronary heart disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1039%2FC1FO10017C

Angiotensin-converting enzyme and male fertility

21 January 2018

1 reference

https://api.crossref.org/works/10.1039%2FC1FO10017C

Structure of human ACE gives new insights into inhibitor binding and design

21 January 2018

1 reference

https://api.crossref.org/works/10.1039%2FC1FO10017C

Antihypertensive effect of sour milk and peptides isolated from it that are inhibitors to angiotensin I-converting enzyme

21 January 2018

1 reference

https://api.crossref.org/works/10.1039%2FC1FO10017C

Alpha-lactorphin and beta-lactorphin improve arterial function in spontaneously hypertensive rats

21 January 2018

1 reference

https://api.crossref.org/works/10.1039%2FC1FO10017C

Angiotensin-I-converting enzyme inhibitory peptides from tryptic hydrolysate of bovine alphaS2-casein

21 January 2018

1 reference

https://api.crossref.org/works/10.1039%2FC1FO10017C

Design of potent competitive inhibitors of angiotensin-converting enzyme. Carboxyalkanoyl and mercaptoalkanoyl amino acids

21 January 2018

1 reference

https://api.crossref.org/works/10.1039%2FC1FO10017C

ACE-inhibitory activity and structural properties of peptide Asp-Lys-Ile-His-Pro [beta-CN f(47-51)]. Study of the peptide forms synthesized by different methods

21 January 2018

1 reference

https://api.crossref.org/works/10.1039%2FC1FO10017C

Angiotensin-converting enzyme-2 (ACE2): comparative modeling of the active site, specificity requirements, and chloride dependence

21 January 2018

1 reference

https://api.crossref.org/works/10.1039%2FC1FO10017C

Bioavailability of angiotensin I converting enzyme inhibitory peptides

21 January 2018

1 reference

https://api.crossref.org/works/10.1039%2FC1FO10017C

Casein fermentate of Lactobacillus animalis DPC6134 contains a range of novel propeptide angiotensin-converting enzyme inhibitors.

21 January 2018

1 reference

https://api.crossref.org/works/10.1039%2FC1FO10017C

Cardiovascular effects of fermented milk containing angiotensin-converting enzyme inhibitors evaluated in permanently catheterized, spontaneously hypertensive rats

21 January 2018

1 reference

https://api.crossref.org/works/10.1039%2FC1FO10017C

Angiotensin I-converting-enzyme-inhibitory and antibacterial peptides from Lactobacillus helveticus PR4 proteinase-hydrolyzed caseins of milk from six species

21 January 2018

1 reference

https://api.crossref.org/works/10.1039%2FC1FO10017C

Food-derived bioactive peptides--opportunities for designing future foods

21 January 2018

1 reference

https://api.crossref.org/works/10.1039%2FC1FO10017C

Anti-hypertensive activity of fermented dairy products containing biogenic peptides

21 January 2018

1 reference

https://api.crossref.org/works/10.1039%2FC1FO10017C

Putting microbes to work: dairy fermentation, cell factories and bioactive peptides. Part I: overview

21 January 2018

1 reference

https://api.crossref.org/works/10.1039%2FC1FO10017C

The proteolytic systems of lactic acid bacteria

21 January 2018

1 reference

https://api.crossref.org/works/10.1039%2FC1FO10017C

Production of angiotensin-I-converting-enzyme-inhibitory peptides in fermented milks started by Lactobacillus delbrueckii subsp. bulgaricus SS1 and Lactococcus lactis subsp. cremoris FT4.

21 January 2018

1 reference

https://api.crossref.org/works/10.1039%2FC1FO10017C

Biochemical properties of regulatory peptides derived from milk proteins

21 January 2018

1 reference

https://api.crossref.org/works/10.1039%2FC1FO10017C

Rapid detection and identification of angiotensin-converting enzyme inhibitors by on-line liquid chromatography-biochemical detection, coupled to electrospray mass spectrometry

21 January 2018

1 reference

https://api.crossref.org/works/10.1039%2FC1FO10017C

Effect of high hydrostatic pressure on the conformation of β-lactoglobulin A as assessed by proteolytic peptide profiling

21 January 2018

1 reference

https://api.crossref.org/works/10.1039%2FC1FO10017C

Characterization of new milk-derived inhibitors of angiotensin converting enzyme in vitro and in vivo

21 January 2018

1 reference

https://api.crossref.org/works/10.1039%2FC1FO10017C

Peptide drug modifications to enhance bioavailability and blood-brain barrier permeability.

21 January 2018

1 reference

https://api.crossref.org/works/10.1039%2FC1FO10017C

Converting a peptide into a drug: strategies to improve stability and bioavailability

21 January 2018

1 reference

https://api.crossref.org/works/10.1039%2FC1FO10017C

Advances in modifying and understanding whey protein functionality

21 January 2018

1 reference

https://api.crossref.org/works/10.1039%2FC1FO10017C

Effect of milk tripeptides on blood pressure: a meta-analysis of randomized controlled trials

21 January 2018

1 reference

https://api.crossref.org/works/10.1039%2FC1FO10017C

Peripheral vascular disease and Virchow's triad for thrombogenesis

21 January 2018

1 reference

https://api.crossref.org/works/10.1039%2FC1FO10017C

Platelet adhesion to damaged coronary arteries: Comparison in normal and von Willebrand disease swine

21 January 2018

1 reference

https://api.crossref.org/works/10.1039%2FC1FO10017C

The structures and proteolytic specificities of autolysed human thrombin

21 January 2018

1 reference

https://api.crossref.org/works/10.1039%2FC1FO10017C

Structural features of a peptide corresponding to human kappa-casein residues 84-101 by 1H-nuclear magnetic resonance spectroscopy

21 January 2018

1 reference

https://api.crossref.org/works/10.1039%2FC1FO10017C

Casein Micelles as Colloids: Surface Structures and Stabilities

21 January 2018

1 reference

https://api.crossref.org/works/10.1039%2FC1FO10017C

Sheep kappa-casein peptides inhibit platelet aggregation.

21 January 2018

1 reference

https://api.crossref.org/works/10.1039%2FC1FO10017C

Liberation of tryptic fragments from caseinomacropeptide of bovine kappa-casein involved in platelet function. Kinetic study

21 January 2018

1 reference

https://api.crossref.org/works/10.1039%2FC1FO10017C

Molecular cloning of a functional thrombin receptor reveals a novel proteolytic mechanism of receptor activation

21 January 2018

1 reference

https://api.crossref.org/works/10.1039%2FC1FO10017C

KRDS, a new peptide derived from human lactotransferrin, inhibits platelet aggregation and release reaction

21 January 2018

1 reference

https://api.crossref.org/works/10.1039%2FC1FO10017C

Adhesion molecules and animal development

21 January 2018

1 reference

https://api.crossref.org/works/10.1039%2FC1FO10017C

Measurement of platelet aggregation peptide inhibitors by ultrasonic interferometry.

21 January 2018

1 reference

https://api.crossref.org/works/10.1039%2FC1FO10017C

The pharmacology of the integrins

21 January 2018

1 reference

https://api.crossref.org/works/10.1039%2FC1FO10017C

Cyclic RGD peptide analogues as antiplatelet antithrombotics

21 January 2018

1 reference

https://api.crossref.org/works/10.1039%2FC1FO10017C

Tomato juice and platelet aggregation in type 2 diabetes

21 January 2018

1 reference

https://api.crossref.org/works/10.1039%2FC1FO10017C

Effects of tomato extract on human platelet aggregation in vitro

21 January 2018

1 reference

https://api.crossref.org/works/10.1039%2FC1FO10017C

Tomatoes have natural anti-thrombotic effects

21 January 2018

1 reference

https://api.crossref.org/works/10.1039%2FC1FO10017C

Effective platelet inhibition by aspirin and clopidogrel: where are we now?

21 January 2018

1 reference

https://api.crossref.org/works/10.1039%2FC1FO10017C

Angiotensin converting enzyme inhibitory peptides derived from food proteins: biochemistry, bioactivity and production

21 January 2018

1 reference

https://api.crossref.org/works/10.1039%2FC1FO10017C

Effect of powdered fermented milk with Lactobacillus helveticus on subjects with high-normal blood pressure or mild hypertension

21 January 2018

1 reference

https://api.crossref.org/works/10.1039%2FC1FO10017C

Lactobacillus helveticus fermented milk lowers blood pressure in hypertensive subjects in 24-h ambulatory blood pressure measurement

21 January 2018

1 reference

https://api.crossref.org/works/10.1039%2FC1FO10017C

Antihypertensive effect of casein hydrolysate in a placebo-controlled study in subjects with high-normal blood pressure and mild hypertension

21 January 2018

1 reference

https://api.crossref.org/works/10.1039%2FC1FO10017C

Effect of casein hydrolysate, prepared with protease derived from Aspergillus oryzae, on subjects with high-normal blood pressure or mild hypertension

21 January 2018

1 reference

https://api.crossref.org/works/10.1039%2FC1FO10017C

Randomized controlled trial of sour milk on blood pressure in borderline hypertensive men.

21 January 2018

1 reference

https://api.crossref.org/works/10.1039%2FC1FO10017C

Effect of ingesting sour milk fermented using Lactobacillus helveticus bacteria producing tripeptides on blood pressure in subjects with mild hypertension

21 January 2018

1 reference

https://api.crossref.org/works/10.1039%2FC1FO10017C

Lactotripeptides show no effect on human blood pressure: results from a double-blind randomized controlled trial

21 January 2018

1 reference

https://api.crossref.org/works/10.1039%2FC1FO10017C

Enzymatically hydrolyzed lactotripeptides do not lower blood pressure in mildly hypertensive subjects

21 January 2018

1 reference

https://api.crossref.org/works/10.1039%2FC1FO10017C

Dose-dependent lowering of blood pressure by dairy peptides in mildly hypertensive subjects

21 January 2018

1 reference

https://api.crossref.org/works/10.1039%2FC1FO10017C

Beneficial potential of casein hydrolysate containing Val-Pro-Pro and Ile-Pro-Pro on central blood pressure and hemodynamic index: a preliminary study

21 January 2018

1 reference

https://api.crossref.org/works/10.1039%2FC1FO10017C

Additive beneficial effects of lactotripeptides and aerobic exercise on arterial compliance in postmenopausal women.

21 January 2018

1 reference

https://api.crossref.org/works/10.1039%2FC1FO10017C

Lactotripeptides do not lower ambulatory blood pressure in untreated whites: results from 2 controlled multicenter crossover studies

21 January 2018

1 reference

https://api.crossref.org/works/10.1039%2FC1FO10017C

Current in vitro testing of bioactive peptides is not valuable

21 January 2018

1 reference

https://api.crossref.org/works/10.1039%2FC1FO10017C

21 January 2018

1 reference

https://api.crossref.org/works/10.1039%2FC1FO10017C

Identification of novel antihypertensive peptides in milk fermented with Enterococcus faecalis

21 January 2018

1 reference

https://api.crossref.org/works/10.1039%2FC1FO10017C

Preparation of ingredients containing an ACE-inhibitory peptide by tryptic hydrolysis of whey protein concentrates

21 January 2018

1 reference

https://api.crossref.org/works/10.1039%2FC1FO10017C

Fibrinogen and Adenosine Diphosphate-induced Aggregation of Platelets

21 January 2018

1 reference

https://api.crossref.org/works/10.1039%2FC1FO10017C

21 January 2018

Identifiers

DOI

10.1039/C1FO10017C

1 reference

release_b77ohtvh7rai5d6oltkuu2zrhq

25 August 2017

1 reference

Fatcat

https://api.fatcat.wiki/v0/release/b77ohtvh7rai5d6oltkuu2zrhq

mapped directly with Wikidata item

24 November 2022

based on heuristic

PubMed ID

21779574

1 reference

PubMed ID

21779574